Current Oncology (Mar 2022)

The Serious Illness Care Program in Oncology: Evidence, Real-World Implementation and Ongoing Barriers

  • Safiya Karim,
  • Oren Levine,
  • Jessica Simon

DOI
https://doi.org/10.3390/curroncol29030128
Journal volume & issue
Vol. 29, no. 3
pp. 1527 – 1536

Abstract

Read online

The Serious Illness Care Program (SICP), designed by Ariadne Labs, is a multicomponent intervention to improve conversations about values and goals for patients with a life-limiting illness. In oncology, implementation of the SICP achieved more, earlier, and better-quality conversations and reduced anxiety and depression among patients with advanced cancer. In this commentary, we describe the SICP, including results from the cluster-randomized trial, provide examples of real-world implementation of this program, and highlight ongoing challenges and barriers that are preventing widespread adoption of this intervention into routine practice. For the SICP to be successfully embedded into routine patient care, it will require significant effort, including ongoing leadership support and training opportunities, champions from all sectors of the interdisciplinary team, and adaptation of the program to a wider range of patients. Future research should also investigate how early conversations can be translated into personalized care plans for patients.

Keywords